Q1 2020 13F Holdings Report, New Holdings, Stock Holdings
Signature - Title
Jon L. Mosle - General Counsel, Chief Operating Officer
Location
Dallas, TX
Holdings as of
31 Mar 2020
Value $
$1,947,014,000
Num holdings
13
Filing time
17 May 2021, 10:52:51 UTC
Form type
13F-HR/A-3 - New Holdings
Description
Top holdings included TIF, WBC, FTSV, CAESARS ENTMT CORP, and HPQ. Request for Confidential Treatment (17 May 2021): Confidential Treatment Expired on 17 May 2021.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
This filing lists securities holdings reported on the form 13F filed on 17 May 2021 pursuant to a request for confidential treatment and for which confidential treatment expired on 17 May 2021.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Jon L. Mosle
General Counsel, Chief Operating Officer
Dallas, Texas
17 May 2021
HBK Investments L.P. has delegated discretion to vote and dispose of the securities described below to HBK Services LLC ("Services"). Services may, from time to time, delegate discretion to vote and dispose of certain of such Securities to one or more subadvisors. Each of Services and such subadvisors is under common control with HBK Investments L.P. The filing of this report shall not be deemed an admission that such subadvisors are, for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, beneficial owners of such securities.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.